Education
About Us
Working with TipRanks
Follow Us
Rossari Biotech Ltd (IN:ROSSARI)
:ROSSARI
Total Valuation
Rossari Biotech Ltd has a market cap or net worth of ₹38.17B. The enterprise value is ₹32.89B.
Market Cap₹38.17B
Enterprise Value₹32.89B
Share Statistics
Rossari Biotech Ltd has 55,366,592 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding55,366,592
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Rossari Biotech Ltd’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 11.00%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)11.00%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover1.16
Inventory Turnover4.62
Valuation Ratios
The current PE Ratio of Rossari Biotech Ltd is 29.57. Rossari Biotech Ltd’s PEG ratio is 3.31.
PE Ratio29.57
PS Ratio0.00
PB Ratio3.59
Price to Fair Value3.69
Price to FCF27.49
Price to Operating Cash Flow21.56
PEG Ratio3.31
Income Statement
In the last 12 months, Rossari Biotech Ltd had revenue of 18.31B and earned 1.31B in profits. Earnings per share was 23.67.
Revenue18.31B
Gross Profit5.26B
Operating Income1.83B
Pretax Income1.78B
Net Income1.31B
EBITDA2.57B
Earnings Per Share (EPS)23.67
Cash Flow
In the last 12 months, operating cash flow was 604.04M and capital expenditures 0.00, giving a free cash flow of 604.04M billion.
Operating Cash Flow604.04M
Free Cash Flow604.04M
Free Cash Flow per Share10.91
Dividends & Yields
Rossari Biotech Ltd pays an annual dividend of ₹0.5, resulting in a dividend yield of 0.07%
Dividend Per Share₹0.5
Dividend Yield0.07%
Payout Ratio1.66%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.95
52-Week Price Change-11.32%
50-Day Moving Average672.91
200-Day Moving Average758.80
Relative Strength Index (RSI)50.89
Average Volume (3m)5.18K
Important Dates
Rossari Biotech Ltd upcoming earnings date is Jul 28, 2025, TBA Not Confirmed.
Last Earnings DateApr 25, 2025
Next Earnings DateJul 28, 2025
Ex-Dividend DateJun 20, 2025
Financial Position
Rossari Biotech Ltd as a current ratio of 1.99, with Debt / Equity ratio of 8.08%
Current Ratio1.99
Quick Ratio1.32
Debt to Market Cap0.03
Net Debt to EBITDA0.36
Interest Coverage Ratio9.43
Taxes
In the past 12 months, Rossari Biotech Ltd has paid 469.26M in taxes.
Income Tax469.26M
Effective Tax Rate0.26
Enterprise Valuation
Rossari Biotech Ltd EV to EBITDA ratio is 15.39, with an EV/FCF ratio of -44.96.
EV to Sales2.16
EV to EBITDA15.39
EV to Free Cash Flow-44.96
EV to Operating Cash Flow91.50
Balance Sheet
Rossari Biotech Ltd has ₹677.94M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹677.94M billion.
Cash & Marketable Securities₹677.94M
Total Debt₹0.00
Net Cash-₹677.94M
Net Cash Per Share-₹12.24
Tangible Book Value Per Share₹142.16
Margins
Gross margin is 29.26%, with operating margin of 9.98%, and net profit margin of 7.14%.
Gross Margin29.26%
Operating Margin9.98%
Pretax Margin9.70%
Net Profit Margin7.14%
EBITDA Margin14.05%
EBIT Margin10.76%
Analyst Forecast
The average price target for Rossari Biotech Ltd is ₹790.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target₹790.00
Price Target Upside13.05% Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―